In the published article, there was an error in Figure 1 as published. In the published article, there were errors in two parts of Figure 1 as published. In Figure 1B , an error occurred in the arrangement of the images. The image corresponding to Mixed CTC’s CD45 (white) was mistakenly placed in the third row, third column, while the image for Mixed CTC’s Mesenchymal (green) was incorrectly positioned in the third row, fourth column. The positions should be swapped to correctly represent the respective markers. In Figure 1C , an error was identified in the second column of the E≈M group. The red fluorescence channel image used in the three-color fluorescence (red, green, blue) image was incorrect and does not accurately represent the intended data. The corrected Figure 1 appears below.
Figure 1.
Use RNA-ISH technology to enrich and analyze CTCs in blood samples of HCC patients (A) The expression of epithelial marker mRNA (EpCAM and E-cadherin) and (B) mesenchymal marker mRNA (Twist and vimentin) and CSC marker mRNA (nanog) were validated by qPCR, p<0.05; (C) The protein expression levels of epithelial markers (EpCAM and E-cadherin), p<0.001. (D–G) The total number of CTCs, epithelial CTCs, mixed CTCs, and mesenchymal CTCs correlated with BCLC staging, p<0.05. **represents P<0.01, *represents P<0.05.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.